Tibet Aim Pharm.Inc. Announces New Board of Directors and Executive Team: Fu Lihua Appointed as Chairman

Deep News09-22

On September 22, Tibet Aim Pharm.Inc. (002826) announced that the company convened its second extraordinary shareholders' meeting of 2025 on September 19, 2025, electing four non-independent directors and three independent directors to form the fourth board of directors.

The non-independent directors include Fu Lihua (Chairman), Huang Lingyi, Yao Yan, and Li Ling (employee representative director). The independent directors comprise He Deming, Chen Yan, and Wang Guangying.

Regarding senior management appointments, the company has hired Xu Ke as General Manager and Chief Financial Officer, Li Qianjin as Board Secretary, Tong Huiying as Head of Internal Audit, and Chen Xi as Securities Affairs Representative.

For the first half of 2025, Tibet Aim Pharm.Inc. achieved revenue of 311 million yuan and net profit attributable to shareholders of 37.56 million yuan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1133142092?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-22 17:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133142092","market":"sh","top_or_hot":-1,"title":"Tibet Aim Pharm.Inc. Announces New Board of Directors and Executive Team: Fu Lihua Appointed as Chairman","media":"Deep News","content":"<p>On September 22, Tibet Aim Pharm.Inc. (002826) announced that the company convened its second extraordinary shareholders' meeting of 2025 on September 19, 2025, electing four non-independent directors and three independent directors to form the fourth board of directors.</p>\n<p>The non-independent directors include Fu Lihua (Chairman), Huang Lingyi, Yao Yan, and Li Ling (employee representative director). The independent directors comprise He Deming, Chen Yan, and Wang Guangying.</p>\n<p>Regarding senior management appointments, the company has hired Xu Ke as General Manager and Chief Financial Officer, Li Qianjin as Board Secretary, Tong Huiying as Head of Internal Audit, and Chen Xi as Securities Affairs Representative.</p>\n<p>For the first half of 2025, Tibet Aim Pharm.Inc. achieved revenue of 311 million yuan and net profit attributable to shareholders of 37.56 million yuan.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tibet Aim Pharm.Inc. Announces New Board of Directors and Executive Team: Fu Lihua Appointed as Chairman</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTibet Aim Pharm.Inc. Announces New Board of Directors and Executive Team: Fu Lihua Appointed as Chairman\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-09-22 17:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On September 22, Tibet Aim Pharm.Inc. (002826) announced that the company convened its second extraordinary shareholders' meeting of 2025 on September 19, 2025, electing four non-independent directors and three independent directors to form the fourth board of directors.</p>\n<p>The non-independent directors include Fu Lihua (Chairman), Huang Lingyi, Yao Yan, and Li Ling (employee representative director). The independent directors comprise He Deming, Chen Yan, and Wang Guangying.</p>\n<p>Regarding senior management appointments, the company has hired Xu Ke as General Manager and Chief Financial Officer, Li Qianjin as Board Secretary, Tong Huiying as Head of Internal Audit, and Chen Xi as Securities Affairs Representative.</p>\n<p>For the first half of 2025, Tibet Aim Pharm.Inc. achieved revenue of 311 million yuan and net profit attributable to shareholders of 37.56 million yuan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"002826","symbol_name":"易明医药","start_time":0,"source_url":"","article_id":"1133142092","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133142092","pubTimestamp":1758532348,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"On September 22, Tibet Aim Pharm.Inc. (002826) announced that the company convened its second extraordinary shareholders' meeting of 2025 on September 19, 2025, electing four non-independent...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"002826":"易明医药","BK0056":"扶贫","BK0033":"西藏振兴","BK0239":"医药制造"},"translate_title":"西藏艾姆制药有限公司。宣布新一届董事会及高管团队：付立华任董事长","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002826":1},"content_text":"On September 22, Tibet Aim Pharm.Inc. (002826) announced that the company convened its second extraordinary shareholders' meeting of 2025 on September 19, 2025, electing four non-independent directors and three independent directors to form the fourth board of directors.\nThe non-independent directors include Fu Lihua (Chairman), Huang Lingyi, Yao Yan, and Li Ling (employee representative director). The independent directors comprise He Deming, Chen Yan, and Wang Guangying.\nRegarding senior management appointments, the company has hired Xu Ke as General Manager and Chief Financial Officer, Li Qianjin as Board Secretary, Tong Huiying as Head of Internal Audit, and Chen Xi as Securities Affairs Representative.\nFor the first half of 2025, Tibet Aim Pharm.Inc. achieved revenue of 311 million yuan and net profit attributable to shareholders of 37.56 million yuan.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1133142092","isCrawlerRequest":true}